A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to … MS Hofman, DG Murphy, SG Williams, T Nzenza, A Herschtal, ... BJU international 122 (5), 783-793, 2018 | 128 | 2018 |
New South Wales drug court evaluation: Cost-effectiveness B Lind, D Weatherburn, S Chen, M Shanahan, E Lancsar, M Haas, ... | 97 | 2002 |
Carrots and sticks—the fall and fall of private health insurance in Australia J Hall, R de Abreu Lourenco, R Viney Health Economics 8 (8), 653-660, 1999 | 95 | 1999 |
Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study RH Osborne, RDA Lourenço, A Dalton, J Houltram, D Dowton, DE Joshua, ... Value in health 10 (6), 451-456, 2007 | 84 | 2007 |
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney-FASTRACK II S Siva, B Chesson, M Bressel, D Pryor, B Higgs, HM Reynolds, ... BMC cancer 18, 1-10, 2018 | 70 | 2018 |
Is prostate-specific membrane antigen positron emission tomography/computed tomography imaging cost-effective in prostate cancer: an analysis informed by the proPSMA trial RE de Feria Cardet, MS Hofman, T Segard, J Yim, S Williams, RJ Francis, ... European urology 79 (3), 413-418, 2021 | 68 | 2021 |
Single-fraction vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases (SAFRON II): the trans tasman radiation oncology group 13.01 phase 2 … S Siva, M Bressel, T Mai, H Le, S Vinod, H de Silva, S Macdonald, ... JAMA oncology 7 (10), 1476-1485, 2021 | 61 | 2021 |
Event-free survival, a prostate-specific antigen–based composite end point, is not a surrogate for overall survival in men with localized prostate cancer treated with radiation W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ... Journal of Clinical Oncology 38 (26), 3032-3041, 2020 | 49 | 2020 |
Risk stratification in children with cancer and febrile neutropenia: a national, prospective, multicentre validation of nine clinical decision rules GM Haeusler, KA Thursky, MA Slavin, FE Babl, RDA Lourenco, Z Allaway, ... EClinicalMedicine 18, 2020 | 43 | 2020 |
Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost M Findlay, C Brown, R De Abreu Lourenço, K White, J Bauer Journal of Human Nutrition and Dietetics 33 (6), 811-821, 2020 | 39 | 2020 |
Bisphosphonate infusions: patient preference, safety and clinic use B Chern, D Joseph, D Joshua, K Pittman, G Richardson, M Schou, ... Supportive care in cancer 12, 463-466, 2004 | 39 | 2004 |
Predicting infectious complications in children with cancer: an external validation study GM Haeusler, KA Thursky, F Mechinaud, FE Babl, R De Abreu Lourenco, ... British journal of cancer 117 (2), 171-178, 2017 | 36 | 2017 |
The Ball–Mankiw Analysis| RDP 9502: Price Stickiness and Inflation R De Abreu Lourenco, D Gruen Reserve Bank of Australia Research Discussion Papers, 1995 | 35* | 1995 |
Cost‐effectiveness of term induction of labour using inpatient prostaglandin gel versus outpatient Foley catheter K Austin, GM Chambers, R de Abreu Lourenco, A Madan, D Susic, ... Australian and New Zealand Journal of Obstetrics and Gynaecology 55 (5), 440-445, 2015 | 34 | 2015 |
Best evidence to best practice: implementing an innovative model of nutrition care for patients with head and neck cancer improves outcomes M Findlay, NM Rankin, T Shaw, K White, M Boyer, C Milross, ... Nutrients 12 (5), 1465, 2020 | 32 | 2020 |
Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia GM Haeusler, R Phillips, MA Slavin, FE Babl, RDA Lourenco, ... EClinicalMedicine 23, 2020 | 30 | 2020 |
Cost-effectiveness of 12-month treatment with ticagrelor compared with clopidogrel in the management of acute coronary syndromes D Liew, RDA Lourenço, M Adena, L Chim, P Aylward Clinical therapeutics 35 (8), 1110-1117. e9, 2013 | 30 | 2013 |
SCORE: shared care of colorectal cancer survivors: protocol for a randomised controlled trial M Jefford, J Emery, E Grunfeld, A Martin, P Rodger, AM Murray, ... Trials 18, 1-10, 2017 | 29 | 2017 |
Grandparents of children with cancer: quality of life, medication and hospitalizations CE Wakefield, JE Fardell, EL Doolan, D Drew, R De Abreu Lourenco, ... Pediatric Blood & Cancer 64 (1), 163-171, 2017 | 29 | 2017 |
Long‐term health‐related quality of life in young childhood cancer survivors and their parents JE Fardell, CE Wakefield, R De Abreu Lourenco, C Signorelli, ... Pediatric blood & cancer 68 (12), e29398, 2021 | 28 | 2021 |